📊 Score Breakdown
Offering Ability
20
Cash Runway
10
Float Risk
25
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for XGN.
💹 Market Data
Market Cap$122.73M
Shares Outstanding24.16M
Float15.10M
Cash$21.51M
Debt$27.15M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 17.9% shares (2025Q4 vs prior)
82 institutional holders · 10.95M shares
#1
Balyasny Asset Management L.P.
919.2K shares
#2
RTW INVESTMENTS, LP
790.5K shares
#3
VANGUARD GROUP INC
790.0K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest724.7K
Days to Cover3.9
% of Float4.8%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2019
3
FORM3
Mar 16, 2026
4
INSIDER TRANSACTION
Mar 16, 2026
4
INSIDER TRANSACTION
Mar 16, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for XGN
📊 XGN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 XGN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.